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Abstract
Patients with neonatal severe hyperparathyroidism (NSHPT) are homozygous for the calcium-sensing receptor (CaR)
mutation and have very high circulating PTH, abundant parathyroid hyperplasia, and severe life-threatening hypercalcemia.
Mice with homozygous deletion of CaR mimic the syndrome of NSHPT. To determine effects of CaR deficiency on skeletal
development and interactions between CaR and 1,25(OH)2D3 or PTH on calcium and skeletal homeostasis, we compared the
skeletal phenotypes of homozygous CaR–deficient (CaR
2/2) mice to those of double homozygous CaR– and 1a(OH)ase–
deficient [CaR
2/21a(OH)ase
2/2] mice or those of double homozygous CaR– and PTH–deficient [CaR
2/2PTH
2/2] mice at 2
weeks of age. Compared to wild-type littermates, CaR
2/2 mice had hypercalcemia, hypophosphatemia, hyperparathyroid-
ism, and severe skeletal growth retardation. Chondrocyte proliferation and PTHrP expression in growth plates were reduced
significantly, whereas trabecular volume, osteoblast number, osteocalcin-positive areas, expression of the ALP, type I
collagen, osteocalcin genes, and serum ALP levels were increased significantly. Deletion of 1a(OH)ase in CaR
2/2 mice
resulted in a longer lifespan, normocalcemia, lower serum phosphorus, greater elevation in PTH, slight improvement in
skeletal growth with increased chondrocyte proliferation and PTHrP expression, and further increases in indices of
osteoblastic bone formation. Deletion of PTH in CaR
2/2 mice resulted in rescue of early lethality, normocalcemia, increased
serum phosphorus, undetectable serum PTH, normalization in skeletal growth with normal chondrocyte proliferation and
enhanced PTHrP expression, and dramatic decreases in indices of osteoblastic bone formation. Our results indicate that
reductions in hypercalcemia play a critical role in preventing the early lethality of CaR
2/2 mice and that defects in
endochondral bone formation in CaR
2/2 mice result from effects of the marked elevation in serum calcium concentration
and the decreases in serum phosphorus concentration and skeletal PTHrP levels, whereas the increased osteoblastic bone
formation results from direct effects of PTH.
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Introduction
The extracellular calcium-sensing receptor (CaR) is a G protein-
coupled receptor that plays an essential role in the regulation of
extracellular calcium homeostasis. This receptor is expressed in
nearly all tissues [1]. Cloning of the CaR was immediately
followed by the association of human genetic diseases with
inactivating or activating CaR mutations: familial hypocalciuric
hypercalcemia (FHH) and neonatal severe hyperparathyroidism
(NSHPT) are caused by CaR-inactivating mutations, whereas
autosomal dominant hypoparathyroidism is secondary to CaR-
activating mutations [1]. Patients with FHH are heterozygous for
the CaR mutation and have a normal or mildly increased
circulating parathyroid hormone (PTH) level, normal parathyroid
histology or mild parathyroid hyperplasia, and mild to moderate
hypercalcemia [2,3]. Patients with NSHPT are homozygous for
the CaR mutation and have very high circulating PTH, abundant
parathyroid hyperplasia and severe life-threatening hypercalcemia
[4]. Targeted inactivation of the CaR gene in mice has resulted in
the development of models of the human syndromes [5]. Thus
mice with heterozygous deletion of CaR mimic the syndrome of
FHH, whereas homozygotes mimic the syndrome of NSHPT and
generally die within a few days to weeks after birth.
A wide variety of functions have been attributed to CaR.
Previous studies confirmed that most CaR
2/2 mice died within 2
weeks after birth [6]. Compared to WT littermates, body size and
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markedly elevated, serum phosphorus levels were decreased,
serum PTH levels were raised significantly in 2-week-old CaR
2/2
mice, and the parathyroid glands were also enlarged. CaR
2/2
mice die shortly after birth because of the effects of severe
hyperparathyroidism and hypercalcemia. However, the lethal
CaR–deficient phenotype has made it difficult to dissect direct
effects of CaR deficiency from secondary effects of hyperparathy-
roidism and hypercalcemia.
Recently, targeted deletion of the CaR from chondrocytes has
been reported to be lethal in utero in mice before embryonic day 13
but to produceviable mice with delayed growth plate development if
conditional targeted deletion in these cells is induced between E16
and E18 [7]. Targeted deletion of the CaR from early committed
osteoblasts resulted in smaller, undermineralized skeletons with
significant reductions in bone volume and bone mineral density in
the femur and vertebrae [7]. This study demonstrated a critical role
for the CaR in skeletal development. However, previous studies
failed to find such role for CaR in mice with targeted disruption of
exon 5 of the CaR gene encoding a portion of the extracellular
domain of this receptor [5,6]. It has not been established that CaR
has a directroleinthe skeleton based on thisanimalmodel. As noted
earlier, these observations may be confounded by the severe
hyperparathyroidism and the accompanying hypercalcemia and
hypophosphatemia in this animal model. To better understand
direct effects of CaR on bone and cartilage function, correction of
hyperparathyroidismisrequiredinthisCaR–deficientmousemodel.
We have previously reported a mouse model deficient in PTH by
targeting the Pth gene in embryonic stem cells [8,9]. Although adult
Pth-null mice develop hypocalcemia, hyperphosphatemia and low
circulating 1,25(OH)2D3 levels consistent with primary hypopara-
thyroidism [9], this phenotype is not lethal. Therefore, a double-
knockout model was established by crossing the PTH-deficient with
the CaR–deficient mice [10] to correct the severe hyperparathy-
roidism, hypercalcemia and hypophosphatemia observed in the
homozygous CaR–deficient mice. The results of this study indicated
that elimination of hyperparathyroidism rescued the increased
neonatal mortality as well as the rickets-like skeletal abnormality in
these mice suggesting that the early lethality could be corrected by
eliminating the hypercalcemia and hyperparathyroidism [10,11].
However, any essential, nonredundant role for CaR in regulating
chondrogenesis or osteogenesis could not be identified based on
analysis of the skeleton of this adult double knockout model. It is
unclear why there are discrepancies between the findings from CaR
conditional knockout mice [7] and those from CaR conventional
knockout mice [6,10] regarding the physiological significance of the
CaR in the skeleton, although residual biological activity of an
alternatively spliced CaR lacking exon 5 in the conventional, global
knockout model may be one explanation.
The vitamin D-PTH axis plays a central role in calcium and
phosphate homeostasis and is essential for skeletal development and
mineralization. PTH and 1,25-dihydroxyvitamin D3 [1,25(OH)2D3]
directly affect calcium homeostasis and each exerts important
regulatory effects on the other. PTH stimulates the production of
1,25(OH)2D3 by activating the renal 25-hydroxyvitamin D-1a-
hydroxylase [1a(OH)ase] [12,13]; 1,25(OH)2D3, in turn, suppresses
the production of PTH [14,15] and controls parathyroid cell growth
[16]. 1,25(OH)2D3 suppression of PTH synthesis occurs through
negative regulation of PTH gene transcription by a 1,25(OH)2D3-
vitamin D receptor (VDR)/retinoid X receptor (RXR) complex [17]
in the parathyroid cells [18]. We [19] and others [20] have
previously reported a mouse model deficient in 1,25(OH)2Db y
targeted ablation of the 1a(OH)ase gene [1a(OH)ase
2/2]. After
being weaned, mice fed a diet of regular mouse chow developed
secondary hyperparathyroidism, retarded growth and skeletal
abnormalities characteristic of rickets. These abnormalities mimic
those described in vitamin D-dependent rickets type I [21] and this
mouse phenotype is not lethal. Furthermore, by comparing mice
with targeted disruption of the PTH or 1a(OH)ase genes with PTH-
1a(OH)ase double null mice, we found that PTH
2/21a(OH)ase
2/2
mice died of tetany with severe hypocalcemia by 3 weeks of age with
severe defects in skeletal development [22].
To determine effects of CaR deficiency on skeletal development as
well as to investigate interactions between CaR, 1,25(OH)2D3 and
PTH on calcium and skeletal homeostasis, we compared the skeletal
phenotypes of CaR
2/2mice to those of the double homozygous, CaR-
and 1a(OH)ase-deficient [CaR
2/21a(OH)ase
2/2]m i c eo rt h o s eo f
the double homozygous CaR- and PTH-deficient [CaR
2/2PTH
2/2]
mice at 2 weeks of age.
Results
Effects of deletion of 1a(OH)ase or PTH on lifespan and
body weight in CaR–deficient mice
In CaR
2/2 mice, the survival rate was 20% and the body
weight was decreased significantly at 2 weeks of age; Ablation of
1a(OH)ase in CaR
2/2 mice resulted in a slightly longer lifespan
and a significant increase of body weight; Ablation of PTH in
CaR
2/2 mice resulted in a normalized lifespan and body weight
(Figure 1A–1D).
Effects of deletion of 1a(OH)ase or PTH on serum
biochemistries and on parathyroid gland size in CaR
2/2
mice
At 2 weeks of age, CaR
2/2 mice displayed hypercalcemia,
hypophosphatemia, and increased serum ALP, PTH and
1,25(OH)2D3;1 a(OH)ase
2/2 mice displayed mild hypocalcemia,
hypophosphatemia, hyperparathyroidism, and undetectable serum
1,25(OH)2D3; PTH
2/2 mice had moderate hypocalcemia and
hyperphosphatemia, lower serum 1,25(OH)2D3 and undetectable
serum PTH; Ablation of 1a(OH)ase in CaR
2/2 mice resulted in
Author Summary
Mice with homozygous deletion of the calcium-sensing
receptor (CaR) mimic the syndrome of neonatal severe
hyperparathyroidism (NSHPT) in humans with very high
circulating parathyroid hormone (PTH) and severe life-
threatening hypercalcemia. To determine effects of CaR
deficiency on skeletal development and interactions
between CaR and 1,25(OH)2D3 or PTH on calcium and
skeletal homeostasis, we compared the skeletal pheno-
types of homozygous CaR–deficient mice to those of
double homozygous CaR– and 1,25(OH)2D3–deficient mice
or those of double homozygous CaR– and PTH–deficient
mice. CaR–deficient mice had hypercalcemia, hypophos-
phatemia, hyperparathyroidism, severe skeletal growth
retardation, and abnormalities; and most died within 2
weeks of age. Deletion of 1,25(OH)2D3 in CaR–deficient
mice resulted in a longer lifespan, normocalcemia, lower
serum phosphorus, greater elevation in PTH, and slight
improvement in skeletal growth. Deletion of PTH in CaR–
deficient mice resulted in rescue of early lethality,
normocalcemia, increased serum phosphorus, and normal-
ization in skeletal growth. Our results indicate that
reductions in hypercalcemia reduce the early lethality of
CaR–deficient mice and that deletion of PTH in patients
with NSHPT may normalize skeletal growth and develop-
ment.
Role of CaR in Skeletal Development
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marked elevations in serum ALP and PTH; In contrast, ablation
of PTH in CaR
2/2 mice resulted in normocalcemia, less severe
hyperphosphatemia, normal serum ALP levels,lower serum
1,25(OH)2D3 and undetectable serum PTH (Table 1).
To determine potential interactions between the effects of CaR
and 1,25(OH)2D3 or PTH on parathyroid gland growth, the size
of the parathyroid glands were examined by histology and image
analysis. The parathyroid glands were mildly enlarged in CaR
2/2
mice (Figure 1E–1H) and 1a(OH)ase
2/2 mice (Figure 1E and
1G), and were significantly enlarged in PTH
2/2 mice compared
(Figure 1F and 1H) to the wild-type mice. Ablation of 1a(OH)ase
in CaR
2/2 mice resulted in further enlargement of the
parathyroid glands (Figure 1E and 1G). Ablation of PTH in
CaR
2/2 mice also resulted in more marked enlargement of
parathyroid glands, which, however, were only slightly more
enlarged relative to PTH
2/2 mice (Figure 1F and 1H).
Effects of deletion of 1a(OH)ase or PTH on the skeletal
development of CaR
2/2 mice
To assess the interaction between CaR and 1,25(OH)2D3 or
PTH on skeletal development, skeletal phenotypes of gender-
matched wild-type and the five mutant models were analyzed at 2
weeks of age by radiography, micro-CT and histology. Radio-
graphs of femurs demonstrated that the lengths of femurs were
dramatically reduced in CaR
2/2 mice, while those of the
1a(OH)ase
2/2 and PTH
2/2 mice were only slightly shortened
compared with their wild-type littermates (Figure 2A). Ablation of
1a(OH)ase in CaR
2/2 mice resulted in an increase in the lengths
of femurs, but they were still shorter than in wild-type mice,
whereas ablation of PTH in CaR
2/2 mice resulted in normali-
zation of the lengths of femurs (Figure 2A). Radiolucency in
metaphyses and diaphyses was increased markedly and no
mineralized epiphyses were detected in CaR
2/2 mice. Radiolu-
cency in whole femurs was slightly increased in 1a(OH)ase
2/2
and PTH
2/2 mice. Ablation of 1a(OH)ase in CaR
2/2 mice
reduced the radiolucency, especially in the metaphyses, and
ablation of PTH in CaR
2/2 mice also reduced the radiolucency
relative to CaR
2/2 mice; however, the radiolucency was still
greater than that in their wild-type littermates (Figure 2A).
From longitudinal and cross sections of three-dimensional recon-
structed proximal ends of tibiae and middle diaphyses (Figure 2B), it
can been seen that mineralized trabecular bone volume in metaphyses
was increased in CaR
2/2 mice, although no mineralized epiphyses
were detected, and mineralized cortical bone volume was reduced in
these mice. Mineralized epiphyseal volume, cortical and trabecular
volume were reduced and the width of unmineralized growth plates
was greater in 1a(OH)ase
2/2 mice. Mineralized cortical and
trabecular bone volumes were reduced in PTH
2/2 mice. Ablation
of 1a(OH)ase in CaR
2/2 mice resulted in a marked increase in
mineralized trabecular bone volume, whereas ablation of PTH in
CaR
2/2mice nearly normalized mineralization in epiphyses, although
mineralized cortical and trabecular bone volumes were still lower than
in their wild-type littermates (Figure 2B). Longitudinal sections of
proximal ends of tibiae stained histochemically for total collagen are
s h o w ni nF i g u r e2 Ca n d2 E ,a n dt r a b e c u l a rv o l u m ew a sm e a s u r e d
(Figure 2G and 2I). Trabecular bone volume was increased
significantly in CaR
2/2 mice and reduced in 1a(OH)ase
2/2 and
PTH
2/2 mice relative to their wild-type littermates. Ablation of
1a(OH)ase in CaR
2/2 mice resulted in a more dramatic increase in
the trabecular bone volume, whereas ablation of PTH in CaR
2/2
mice resulted in a marked reduction in the trabecular bone volume,
Figure 1. Effects of deletion of 1a(OH)ase or PTH on lifespan, body weight, and parathyroid gland size in CaR–deficient mice. (A)
Lifespan of CaR
2/2 mice with varying 1a(OH)ase status. (B) Lifespan of CaR
2/2 mice with varying PTH status. (C) Body weight of CaR
2/2 mice with
varying 1a(OH)ase status at 2 weeks of age. (D) Body weight of CaR
2/2 mice with varying PTH status at 2 weeks of age. (E, F) Representative
micrographs of sections of parathyroid glands (arrows) and adjacent thyroid tissues stained with hematoxylin and eosin (HE). Scale bars in K and L
represent 100 mm. (G, H) Parathyroid areas. Each value is the mean6SEM of determinations in 6 mice of the same genotype. *, P,0.05; **, P,0.01;
***, P,0.001 compared with wild-type mice. ##,P ,0.01; ###,P ,0.001 compared with CaR
2/2 mice.
doi:10.1371/journal.pgen.1002294.g001
Table 1. Effects of deletion of 1a(OH)ase or PTH on serum biochemistries in CaR
2/2 mice.
WT CaR
2/2 1a(OH)ase
2/2 CaR
2/21a(OH)ase
2/2
Serum calcium (mmol/L) 2.760.07 3.960.22*** 2.460.05* 2.660.08
###
Serum phosphorus (mmol/L) 3.360.14 1.460.20*** 2.760.18* 1.060.05***
##
Serum ALP (IU/L) 304655.5 18806203*** 461615.3* 2240644.1***
#
Serum PTH (pg/ml) 18.465.02 311611.4*** 28.163.34* 492630.2***
##
Serum 1,25(OH)2D3 (pg/ml) 158612.3 314632.5*** 0 0
WT CaR
2/2 PTH
2/2 CaR
2/2PTH
2/2
Serum calcium (mmol/L) 2.560.06 4.260.20*** 1.660.12** 2.260.11
###
Serum phosphorus (mmol/L) 3.660.14 1.560.23*** 4.560.17** 4.160.19*
###
Serum ALP (IU/L) 294648.8 18206199*** 363615.3 361622.9
###
Serum PTH (pg/ml) 20.164.23 323615.8*** 0 0
Serum 1,25(OH)2D3 (pg/ml) 15469.81 322628.9*** 128618.2 98.4621.3**
###
*, P,0.05;
**, P,0.01;
***, P,0.001 compared with wild-type mice;
#,P ,0.05;
##,P ,0.01;
###,P ,0.001 compared with CaR
2/2 mice.
doi:10.1371/journal.pgen.1002294.t001
Role of CaR in Skeletal Development
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2/2 mice (Figure 2C, 2E, 2G and 2I). Osteoid
volume was increased significantly in CaR
2/2 and CaR
2/2
1a(OH)ase
2/2 mice, and was not altered significantly in
1a(OH)ase
2/2,P T H
2/2 and CaR
2/2PTH
2/2 mice relative to
their wild-type littermates (Figure 2D, 2F, 2H and 2J).
Effects of deletion of 1a(OH)ase or PTH on endochondral
bone formation in CaR
2/2 mice
To assess the interaction between CaR and 1,25(OH)2D3 or
PTH on endochondral bone formation, the phenotypes of growth
plates were analyzed at 2-weeks of age by histology and
immunohistochemistry. Only a few hypertrophic chondrocytes
were observed in secondary ossification centers, and the width of
growth plates and hypertrophic zones were increased dramatically
in CaR
2/2 mice, increased in 1a(OH)ase
2/2 mice and not
altered in PTH
2/2 mice relative to their wild-type littermates.
Ablation of 1a(OH)ase in CaR
2/2 mice accelerated slightly the
formation of secondary ossification centers, resulted in more
hypertrophic chondrocytes and the appearance of some osteo-
blasts and the width of growth plates and hypertrophic zones were
reduced significantly. Ablation of PTH in CaR
2/2 mice
normalized the secondary ossification centers and the growth
plates (Figure 3A, 3D, 3E and Figure 4A, 4D, 4E).
The proliferation of chondrocytes was assessed by immuno-
staining for proliferating cell nuclear antigen (PCNA), and the
percentage of PCNA-positive chondrocytes was quantitated. The
percentage of PCNA-positive chondrocytes was reduced dramat-
ically in CaR
2/2 mice, and was not altered significantly in
1a(OH)ase
2/2 and PTH
2/2 mice. Ablation of 1a(OH)ase in
CaR
2/2 mice increased significantly the percentage of PCNA-
positive chondrocytes; however, it was still lower than in their
wild-type littermates. Ablation of PTH in CaR
2/2 mice increased
the percentage of PCNA-positive chondrocytes more dramatically,
to a level even higher than that in their wild-type littermates
(Figure 3B, 3F and Figure 4B, 4F).
In view of the fact that PTHrP plays an important role in the
proliferation and apoptosis of chondrocytes, we examined the
localization of PTHrP in chondrocytes by immunostaining and the
expression of the PTHrP gene in cartilaginous growth plates. The
percentage of PTHrP-positive chondrocytes was reduced mark-
edly in CaR
2/2 mice, reduced significantly in 1a(OH)ase
2/2
mice and increased in PTH
2/2 mice. Ablation of 1a(OH)ase in
CaR
2/2 mice increased significantly the percentage of PTHrP-
positive chondrocytes; however, it was still lower than in their
wild-type littermates. Ablation of PTH in CaR
2/2 mice increased
markedly the percentage of PTHrP-positive chondrocytes
(Figure 3C, 3G and Figure 4C, 4G). Alteration in the pattern of
expression of the PTHrP gene in cartilaginous growth plates were
similar to those observed for the percentage of PTHrP positive
chondrocytes (Figure 3H and Figure 4H).
Effects of deletion of 1a(OH)ase or PTH on osteoblastic
bone formation in CaR
2/2 mice
To determine whether alterations in trabecular bone volume
were associated with those in osteoblastic bone formation, paraffin
sections from the various genotypes of mice at 2 weeks of age were
stained with HE (Figure 5A and 5C) as well as immunohisto-
chemically for osteocalcin (Figure 5B and 5D). The number of
osteoblasts (Figure 5E and 5F) and osteocalcin-positive areas
(Figure 5G and 5H) in metaphyseal regions were quantitated by
image analysis. The number of osteoblasts and osteocalcin-positive
areas were increased significantly in CaR
2/2 mice, while they
were reduced in 1a(OH)ase
2/2 and PTH
2/2 mice relative to
their wild-type littermates. Ablation of 1a(OH)ase in CaR
2/2
mice resulted in a more dramatic increase in the number of
osteoblasts and osteocalcin-positive areas, whereas ablation of
PTH in CaR
2/2 mice resulted in a marked reduction in the
number of osteoblasts and osteocalcin-positive areas, even
compared to PTH
2/2 mice (Figure 5A–5H). We also examined
alterations in the expression of genes related to bone formation.
RNA was isolated from long bones and real-time RT–PCR was
performed. Results showed that the expression of the ALP, type I
collagen and osteocalcin genes were increased significantly in
CaR
2/2 mice, while they were reduced in 1a(OH)ase
2/2 and
PTH
2/2 mice relative to their wild-type littermates. Ablation of
1a(OH)ase in CaR
2/2 mice resulted in a more dramatic increase
in the expression of these same genes, whereas ablation of PTH in
CaR
2/2 mice resulted in a marked reduction in their expression,
even compared to PTH
2/2 mice (Figure 5I and 5J). These
alterations were consistent with those of osteoblastic bone
formation parameters observed by histomorphometric analysis.
Effects of deletion of 1a(OH)ase or PTH on osteoclastic
bone resorption in CaR
2/2 mice
To assess the interaction between CaR and 1,25(OH)2D3 or
PTH on osteoclastic bone resorption, paraffin sections were
stained histochemically for TRAP (Figure 6A and 6B). Osteoclast
number (Figure 6C and 6D) and surface (Figure 6E and 6F) were
determined by image analysis. The results revealed that the
TRAP-positive osteoclast number and surface were increased
markedly in the metaphyseal regions in CaR
2/2 mice and were
decreased significantly in 1a(OH)ase
2/2 and PTH
2/2 mice
relative to their wild-type littermates. Ablation of 1a(OH)ase in
CaR
2/2 mice decreased significantly osteoclast number and
surface; however, these parameters were still greater than in their
wild-type littermates. Ablation of PTH in CaR
2/2 mice markedly
decreased osteoclast number and surface (Figure 6A–6F). We also
examined alterations in the expression of genes related to bone
resorption. RNA was isolated from long bones. The gene
expression of the RANKL and OPG genes were examined by
real-time RT–PCR, and the ratio of RANKL/OPG mRNA levels
was calculated. Results revealed that alterations in the ratio of
RANKL/OPG mRNA levels were consistent with those of TRAP-
positive osteoclast number and surface (Figure 6G and 6H).
Discussion
In the present study, we examined the effect on mineral
homeostasis of deleting CaR (CaR
2/2) alone, or both
1,25(OH)2D3 and CaR (1a(OH)ase
2/2CaR
2/2), or both PTH
Figure 2. Effects of deletion of 1a(OH)ase or PTH on the skeletal development of CaR–deficient mice. (A) Representative contact
radiographs of femurs from 2-week-old wild-type (WT), CaR
2/2,1 a(OH)ase
2/2, PTH
2/2, CaR
2/21a(OH)ase
2/2 and CaR
2/2PTH
2/2 mice. (B)
Representative longitudinal and cross sections of three-dimensional reconstructed proximal ends of tibiae and mid shaft diaphyses utilizing micro-CT.
(C, E) Representative micrographs of decalcified paraffin-embedded sections of the proximal ends of tibiae stained histochemically for total collagen.
(D, F) Representative micrographs from undecalcified sections of the proximal ends of tibiae stained by the von Kossa procedure. Scale bars represent
200 mm in C and E and 25 mm in D and F. (G, I) Trabecular bone volume relative to tissue volume (BV/TV, %). (H, J) Osteoid volume relative to bone
volume (OV/BV, %). Each value is the mean6SEM of determinations in 6 mice of the same genotype. **, P,0.01; ***, P,0.001 compared with wild-
type mice; #,P ,0.05; ##,P ,0.01; ###,P ,0.001 compared with CaR
2/2 mice.
doi:10.1371/journal.pgen.1002294.g002
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2/2CaR
2/2). Our results confirmed previous
findings in CaR
2/2 mice: namely the presence of hypercalcemia,
hypophosphatemia, hyperparathyroidism and enlarged parathy-
roid glands [5,6]. Deletion of 1a(OH)ase in the CaR null
background corrects the hypercalcemia but leads to more severe
hypophosphatemia, hyperparathyroidism and much larger para-
thyroid glands. These alterations were associated with diminished
capacity of double knockout mice to stimulate absorption of
calcium and phosphate from the gastrointestinal tract and to
repress PTH biosynthesis, and resulted in a further stimulus for
parathyroid gland enlargement, overproduction of parathyroid
hormone and consequent effects on impeding renal phosphate
Figure 3. Effects of deletion of 1a(OH)ase on endochondral bone formation in CaR–deficient mice. Paraffin-embedded sections of tibiae
from 2-week-old wild-type (WT), CaR
2/2,1 a(OH)ase
2/2 and CaR
2/21a(OH)ase
2/2 mice stained (A) with HE, (B) immunohistochemically for PCNA, and
(C) immunohistochemically for PTHrP. Scale bars in A, B and C represent 100, 25 and 25 mm. Width of (D) growth plates and (E) hypertrophic zones of
growth plates. (F) The percentage of PCNA-positive chondrocytes relative to total chondrocytes. (G) The percentage of PTHrP-positive chondrocytes
relative tototalchondrocytes. (H)ComparisonofPTHrPgeneexpressionlevelsingrowthplatesofWT,CaR
2/2,1 a(OH)ase
2/2 andCaR
2/21a(OH)ase
2/2
mice. Specific PTHrP products were amplified from the tissue RNAs by real-time RT–PCR as described in Materials and Methods. Messenger RNA
expression assessed by real-time RT–PCR analysis was calculated as a ratio to the GAPDH mRNA level and expressed relative to levels of WT mice. Each
value is the mean6SEM of determinations in 6 mice of the same genotype. *, P,0.05; **, P,0.01; ***, P,0.001 compared with wild-type mice; #,
P,0.05; ##,P ,0.01; ###,P ,0.001 compared with CaR
2/2 mice.
doi:10.1371/journal.pgen.1002294.g003
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2/2 mice also
corrects the hypercalcemia, and the mice develop hyperphospha-
temia and undetectable serum PTH with enlarged parathyroid
glands. These alterations were associated with diminished capacity
of double mutant animals to stimulate calcium reabsorption and to
inhibit phosphate reabsorption from the renal tubules [23].
Reduction of hypercalcemia in the CaR
2/2 mice was the
common biochemical alteration induced by deleting the
1a(OH)ase in the CaR
2/21a(OH)ase
2/2 mice and PTH in the
CaR
2/2PTH
2/2 mice. Improvement in hypercalcemia is there-
fore likely to have been the major contributor to the improved
longevity of the CaR
2/2 mice.
Figure 4. Effects of deletion of PTH on endochondral bone formation in CaR–deficient mice. Paraffin-embedded sections of tibiae from 2-
week-old wild-type (WT), CaR
2/2, PTH
2/2 and CaR
2/2PTH
2/2 mice stained (A) with HE, (B) immunohistochemically for PCNA and (C)
immunohistochemically for PTHrP. Scale bars in A, B and C represent 100, 25 and 25 mm. Width of (D) growth plates and (E) hypertrophic zones of
growth plates. (F) The percentage of PCNA-positive chondrocytes relative to total chondrocytes. (G) The percentage of PTHrP-positive chondrocytes
relative to total chondrocytes. (H) Comparison of PTHrP gene expression levels in growth plates of WT, CaR
2/2, PTH
2/2 and CaR
2/2PTH
2/2 mice.
Specific PTHrP products were amplified from the tissue RNAs by real-time RT–PCR as described in Materials and Methods. Messenger RNA expression
assessed by real-time RT–PCR analysis was calculated as a ratio to the GAPDH mRNA level and expressed relative to levels of WT mice. Each value is
the mean6SEM of determinations in 6 mice of the same genotype. *, P,0.05; ***, P,0.001 compared with wild-type mice; ###,P ,0.001 compared
with CaR
2/2 mice.
doi:10.1371/journal.pgen.1002294.g004
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PLoS Genetics | www.plosgenetics.org 8 September 2011 | Volume 7 | Issue 9 | e1002294Figure 5. Effects of deletion of 1a(OH)ase or PTH on osteoblastic bone formation in CaR–deficient mice. Representative micrographs of
paraffin-embedded sections of tibiae from 2-week-old wild-type (WT), CaR
2/2,1 a(OH)ase
2/2, PTH
2/2, CaR
2/21a(OH)ase
2/2 and CaR
2/2PTH
2/2 mice
stained (A, C) with HE, (B, D) or immunohistochemically for osteocalcin (OCN). Scale bars represent 50 mm in A–D. (E, F) Number of osteoblasts per
tissue area (N.Ob/T.Ar, #/mm
2). (G, H) Osteocalcin-positive area as a percent of the tissue area. (I, J) Real-time RT–PCR of long bone tissue extracts for
the expression of ALP, type I collagen (Col I) and OCN. Messenger RNA expression assessed by real-time RT–PCR is calculated as a ratio to the GAPDH
mRNA level and expressed relative to levels of WT mice. Each value is the mean 6 SEM of determinations in 6 animals of the same genotype.
*, P,0.05; **, P,0.01; ***, P,0.001 compared with wild-type mice; #,P ,0.05; ##,P ,0.01; ###,P ,0.001 compared with CaR
2/2 mice.
doi:10.1371/journal.pgen.1002294.g005
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the nuclear vitamin D receptor (VDR) to bind to a negative
response element tentatively identified in the PTH promoter, which
can repress PTH gene expression [17]. We previously showed that
1,25(OH)2D3 can inhibit the growth of primary cultures of bovine
parathyroid cells in vitro [24]. We also showed that 1,25(OH)2D3
inhibits parathyroid hyperplasia in vivo in a mouse model with
targeted ablation of the 1a(OH)ase gene [25]. Our current study
found more severe hypophosphatemia and hyperparathyroidism
withenlarged parathyroid glands in 2-week-old double homozygous
CaR- and 1a(OH)ase-deficient neonates than in CaR
2/2 mice,
indicating that 1,25(OH)2D3 inhibits parathyroid growth and PTH
biosynthesis in a CaR-independent manner.
We next examined the effect of CaR deficiency and the
interaction between CaR and 1,25(OH)2D3 or PTH on endo-
chondral bone formation. Our results show that CaR deficiency
resulted in a severe delay of secondary ossification center
formation, an enlarged growth plate and a significant reduction
of chondrocyte proliferation and apoptosis. Genetic deficiencies in
1,25(OH)2D3 caused by loss of a functional 1a(OH)ase enzyme or
vitamin D receptor (VDR) result in hypocalcemia, hyperparathy-
roidism, hypophosphatemia, rickets, and osteomalacia. These
effects, however, are very mild or absent in suckling mice but
become markedly accelerated in mice after weaning, when dietary
calcium and lactose content decreases. The phenotype can largely
be corrected by administration of a high calcium, high lactose-
Figure 6. Effects of deletion of 1a(OH)ase or PTH on osteoclastic bone resorption in CaR–deficient mice. (A, B) Representative
micrographs of paraffin-embedded sections of tibiae from 2-week-old wild-type (WT), CaR
2/2,1 a(OH)ase
2/2, PTH
2/2, CaR
2/21a(OH)ase
2/2 and
CaR
2/2PTH
2/2 mice stained histochemically for tartrate-resistant acid phosphatase activity (TRAP). Scale bars in A and B represent 50 mm. (C, D)
Number of TRAP-positive osteoclasts per tissue area (N.Oc/T.Ar, #/mm
2) and (E, F) the surface of osteoclasts relative to the bone surface (Oc.S/B.S, %).
Each value is the mean 6 SEM of determinations in 6 animals in each group. (G, H) Real-time RT–PCR was performed on long bone tissue extracts for
RANKL and OPG mRNA as described in Materials and Methods. Messenger RNA expression assessed by real-time RT–PCR analysis is calculated as a
ratio to the GAPDH mRNA level and expressed relative to levels of wild-type mice. Ratio of RANKL/OPG relative mRNA levels was calculated. Each
value is the mean 6 SEM of determinations in 6 animals of the same genotype. *, P,0.05; **, P,0.01; ***, P,0.001 compared with wild-type mice;
#,P ,0.05; ##,P ,0.01; ###,P ,0.001 compared with CaR
-/- mice.
doi:10.1371/journal.pgen.1002294.g006
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2+
absorption [25]. It is noteworthy that analysis of the chondrocyte-
specific Cyp27b1-knockout and Cyp27b1-overexpressing mice
revealed a fetal bone phenotype which did not persist however
beyond the immediate neonatal period [26]. Consequently
although 1,25(OH)2D3 may play a direct role in normal
development of the cartilaginous growth plate, other factors, such
as endocrine maintenance of calcium and phosphate balance may
be more important in defining postnatal bone development. The
deletion of 1a(OH)ase in CaR
2/2 mice slightly accelerated
secondary ossification center formation, and improved chondro-
cyte proliferation, while deletion of PTH in CaR
2/2 mice rescued
these abnormalities of cartilaginous development in CaR
2/2
mice. This result is consistent with a previous report in which
correction of severe hyperparathyroidism in CaR
2/2 mice
resulted in healing of the rickets and osteomalacia [11]. In our
studies, the normalization of serum calcium in both double
mutants may have accelerated the improvements in the secondary
ossification centre and in the cartilaginous growth plate.
Previous studies have reported that the CaR modulates growth
plate chondrocyte differentiation in vitro [27–29], and chondro-
cyte-specific CaR deletion leads to early embryonic death (before
E13). However, if the deletion occurs at the later time points, such
as between E16 and E18, viable pups can be obtained but with
delayed growth plate development [7]. Currently, there is no fully
accepted explanation for these discrepancies in phenotype
between chondrocyte-specific CaR knockout mice obtained using
mice with a floxed exon 7 of the CaR gene [7] and the CaR
conventional knockout mice in which exon 5 has been disrupted
[6,10]. Because calcium regulation is so fundamental for the
maintenance of normal cell function, it is plausible that cells have
some other pathways that can compensate for neonatal defects
resulting from deficiency of CaR. One such compensatory
mechanism may be the expression of a CaR splice variant lacking
exon 5 in chondrocytes from the CaR–deficient mice [30].
In the PTH
2/2CaR
2/2 mice complete rescue of the alterations
in the secondary ossification centre and in the cartilaginous growth
plate were observed. In view of the fact that PTH is not
synthesized in cartilage, it cannot access this avascular tissue. It
seems likely that, since phosphate per se plays a critical role in
growth plate development (30), and mineralization [31] and
phosphate levels are also markedly decreased in CaR
2/2 mice and
increased by deletion of PTH, hyperphosphatemia in the CaR
2/2
PTH
2/2 mice likely contributed to the improvement in the
growth plate.
PTHrP-deficient mice display reduced chondrocyte prolifera-
tion, accelerated differentiation, and increased apoptosis [31,32].
Our previous study demonstrated that 4-month old PTH
2/2 mice
have significantly increased serum PTHrP concentrations and
PTHrP mRNA and protein levels in bone tissues, suggesting that
PTHrP is required for the increased trabecular bone volume
observed in adult PTH
2/2 mice [33]. Based on these findings, we
hypothesized that altered PTHrP levels might account for the
skeletal defects of CaR
2/2 mice and play a compensatory role in
PTH/CaR double knockout mice. To test this hypothesis, we
examined the levels of expression of PTHrP mRNA and protein in
cartilaginous growth plates by real-time RT-PCR and immuno-
histochemistry, respectively. PTHrP-immunopositive chondro-
cytes and PTHrP mRNA levels were markedly decreased in
CaR
2/2 mice, slightly increased in CaR
2/21a(OH)ase
2/2 mice,
and increased significantly in CaR
2/2PTH
2/2 mice compared to
their wild-type littermates. These results demonstrate that down-
regulation of PTHrP expression in chondrocytes is associated with
defects in the growth plate caused by CaR deficiency and that up-
regulation of PTHrP expression is associated with either
improvement or rescue of chondrocyte abnormalities resulting
from the deletion of either 1a(OH)ase or PTH, in the CaR–
deficient mice. 1,25(OH)2D3 has been reported to dampen PTHrP
upregulation at both the mRNA and protein levels in prostate
cancer cells [34,35]. 1,25(OH)2D3 deficiency may therefore have
contributed to the increases of PTHrP observed in the double
mutants. Taken together, these data suggest that the down-
regulation of PTHrP expression in chondrocytes may contribute to
defects of cartilage in the CaR–deficient neonates and that up-
regulation of PTHrP expression in chondrocytes may exert a
contributory role in rescuing these abnormalities.
We also examined the effect of 1,25(OH)2D3 or PTH deficiency
in CaR
2/2 mice on osteoblastic bone formation. CaR–deficient
mice showed increased trabecular volume, osteoblast number, and
osteocalcin-positive areas, as well as increased expression of the
ALP, type I collagen and osteocalcin genes and higher serum ALP
levels. These osteoblastic bone formation parameters increased
dramatically in 1a(OH)ase/CaR double knockout mice, despite
the fact that these parameters were slightly decreased in
1a(OH)ase-deficient neonates. These results are consistent with
our previous findings from 2-week-old [22] and adult
1a(OH)ase
2/2 mice [19,25]. When the phenotype of
1a(OH)ase
2/2 mice was analyzed, we found that the skeletal
phenotype was different before and after weaning. In 2-week-old
1a(OH)ase
2/2 mice, the trabecular volume and osteoblast
numbers were decreased, and the osteoid volume was not
increased significantly [22]. In contrast, in 4-month-old
1a(OH)ase
2/2 mice, the trabecular volume, osteoblast number
and osteoid volume were all increased significantly even on a high
calcium diet containing 1.5% calcium in the drinking water [25].
These differences were thought to result from the elevations in
circulating PTH. Breast-feeding of neonatal 1a(OH)ase
2/2 pups
with milk containing a higher calcium and low level of
1,25(OH)2D3 had less severe hypocalcemia and subsequent less
elevation of serum PTH compared to adult mutant mice. Our
previous studies had shown that serum PTH was increased 1.5-
fold at 2 weeks of age [22], but 30-fold at 4 months of age [25], in
the 1a(OH)ase
2/2 mice compared to their wild-type counterparts.
If the stimulatory effects of elevated PTH on osteoblasts could not
overcome the reduction in osteoblasts due to 1,25(OH)2D3
deficiency, osteoblastic bone formation parameters would be
reduced. If, on the other hand, the osteoblast-stimulating effects of
elevated PTH overcame the decreased osteoblasts resulting from
1,25(OH)2D3 deficiency, then osteoblastic bone formation param-
eters would be increased. The presence of increased numbers of
osteoblasts and increased bone matrix volume in CaR
2/2 and
CaR
2/21a(OH)ase
2/2 neonates suggests that any requirement of
either CaR or/and 1,25(OH)2D3 for osteoblast activation is
readily overcome by the osteoblast stimulating effects of elevated
PTH. This observation was further supported by deletion of PTH
in the CaR
2/2 mice, which resulted in a significant decrease in
osteoblastic bone formation compared to PTH
2/2 mice. The
difference in osteoblastic bone formation between the PTH
2/2
and CaR
2/2PTH
2/2 mice and which can be accentuated in
older animals [36] is consistent with a stimulatory effect of CaR on
osteoblast function. Indeed, exposure of primary osteoblasts or a
variety of osteoblast-like cells to high calcium or polycationic CaR
agonists, such as neomycin and gadolinium, stimulate their
proliferation, differentiation and mineralization [37,38].
Previous studies have revealed that calcium is also an important
regulator of osteoclast function. Exposing osteoclasts to high
extracellular calcium concentrations results in dramatic cell
retraction followed by profound inhibition of bone resorption
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the bone-resorbing activity of osteoclasts by directly acting on the
CaR that is present in osteoclast precursor cells [42] and mature
osteoclasts [43,44]. Our results found that TRAP-positive
osteoclast number and surface and the ratio of RANKL/OPG
were increased in CaR
2/2 mice. Deletion of 1a(OH)ase in CaR
2/2
neonates resulted in a decrease in osteoclastic bone resorption
parameters, however, these parameters were higher than in
1a(OH)ase neonates. Deletion of PTH in CaR
2/2 neonates also
resulted in a decrease in these parameters. As in our previous report
[22], the current study confirms that osteoclastic bone resorption
parameters were reduced in either 1a(OH)ase
2/2 or PTH
2/2
neonates. Taken together, these studies suggest that the CaR,
1,25(OH)2D3 and PTH are all required for osteoclastic bone
resorption.
Results from this study indicate that normocalcemia in patients
with NSHPT may lengthen their lifespan, and deletion of PTH in
patients with NSHPT may normalize skeletal growth and
development. A previous study has reported that the use of
intravenous pamidronate controlled severe hypercalcaemia in
NSHPT patients prior to parathyroidectomy [45], Consequently,
they recommended the short-term use of pamidronate in neonatal
severe hyperparathyroidism to treat extreme hypercalcaemia and
halt hyperparathyroid-driven skeletal demineralization in prepa-
ration for parathyroidectomy. Recently, a retrospective review has
been conducted for patients managed for NSHPT over the last 10
years [46]. Five patients with NSHPT, 3 females and 2 males,
presented at a mean age of 18 days. All patients had a total
parathyroidectomy and autotransplantation at a mean age of 65
days, with a mean follow-up of 5.5 years. One patient had normal
parathyroid hormone and normal calcium levels 9.5 years after
surgery without medication. One patient had normal levels
without medication for 2 years then needed calcium and vitamin
D supplements thereafter (8.5 years postoperatively). Three
patients are still on calcium and vitamin D supplementation at
5.5 years, 3.5 years, and 8 months, respectively, after surgery.
Consequently, they conclude that NSHPT is managed effectively
with total parathyroidectomy [46].
In summary (Table 2), CaR
2/2 mice had a very short lifespan,
decreased body weight and displayed hypercalcemia, hypophos-
phatemia, elevated serum ALP, PTH and 1,25(OH)2D3; CaR
2/2
1a(OH)ase
2/2 mice had slightly increased lifespan and body
weight and displayed normocalcemia, hypophosphatemia, greater
elevations in PTH and ALP, and undetectable serum
1,25(OH)2D3; CaR
2/2PTH
2/2 mice displayed normocalcemia,
hyperphosphatemia, normal ALP levels, undetectable serum PTH
and lower serum 1,25(OH)2D3. CaR deficiency resulted in a
severe delay of secondary ossification center formation, an
enlarged growth plate and a significant reduction of chondrocyte
proliferation. These alterations were associated with hypophos-
phatemia and decreased PTHrP expression in chondrocytes.
Deletion of 1a(OH)ase in CaR
2/2 mice partially rescued the
cartilage phenotype associated with an increase in PTHrP
expression in chondrocytes but persistent hypophosphatemia.
Deletion of PTH in CaR
2/2 mice rescued the phenotype of
cartilage associated with the up-regulation of PTHrP expression in
chondrocytes and correction of hypophosphatemia. The alter-
ations of bone formation parameters were consistent with elevated
serum PTH and with the reduction of PTHrP gene expression in
bony tissue in CaR
2/2 and CaR
2/2 1a(OH)ase
2/2 mice.
Deletion of PTH in CaR
2/2 mice resulted in a significant
decrease in osteoblastic bone formation, which was not rescued
completely by increased PTHrP gene expression in bony tissue.
Osteoclastic bone resorption parameterswere increased in CaR
2/2
mice, however, they were decreased in CaR
2/21a(OH)ase
2/2
mice and more dramatically in CaR
2/2PTH
2/2 mice compared
Table 2. Summary of interactions among CaR, 1,25(OH)2D3, and PTH on mineral and skeletal homeostasis.
CaR
2/2 CaR
2/21a(OH)ase
2/2 CaR
2/2PTH
2/2
Changes of lifespan and bone weight
Lifespan QQQ QQ R
Body weight QQQ QQ R
Mineral ion homeostasis
Serum calcium qqq R R
Serum phosphorus QQ QQQ q
Serum ALP qq qqq R
Serum PTH qq qqq —
Serum 1,25(OH)2D3 qqq — Q
Cartilage changes
Secondary ossification center QQQ QQ R
Width of growth plate qqq q R
Chondrocyte proliferation QQQ QQ q
PTHrP
+ chondrocytes QQQ QQ q
Bone changes
Trabecular bone volume qq qqq Q
Osteoblast production qq qqq Q
Bone mineralization QQQ QQ R
Osteoclast production qq q R
Q, a reduction; q, an increase; R, no change. and —, undetectable. Repetitive arrows indicate the magnitude of the change.
doi:10.1371/journal.pgen.1002294.t002
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2/2 littermates. The current study demonstrates that (1)
hypercalcemia, contributes to the early lethality of CaR–deficient
mice, (2) defects in endochondral bone formation in CaR–deficient
mice result from effects of the excess elevations in calcium and the
decrease in phosphorus and PTHrP levels, while (3) the increased
osteoblastic bone formation results from direct effects of PTH. Our
results therefore provide mechanistic insight into the improvement
in longevity and normalization in skeletal growth and development
observed in patients with NSHPT after total parathyroidectomy.
Materials and Methods
Derivation of CaR/1a(OH)ase double null mice and CaR/
PTH double null mice
The derivation of the three parental strains of CaR
+/2, PTH
+/2
mice and 1a(OH)ase
+/2 mice by homologous recombination in
embryonic stem cells was previously described by Ho et al. [5],
Miao et al. [8,9] and Panda et al.[19], respectively. Briefly, a
neomycin resistance gene was inserted into exon III of the mouse
CaRgeneorintoexonIIIofthe mousePthgene,replacingaportion
of the extracellular domain of the CaR, which senses extracellular
calcium, and the entire coding sequence of the PTH gene. Lack of
CaR and PTH expression were confirmed by Western blot of
kidneyproteinmembraneextractsfrom homozygousCaR
2/2 mice
[5] and by immunostaining of parathyroid glands sections [8],
respectively. A neomycin resistance gene replaced exons VI, VII,
and VIII of the mouse 1a(OH)ase gene, removing both the ligand-
binding and the heme-binding domains. RT–PCR of renal RNA
from homozygous 1a(OH)ase
2/2 mice confirmed the lack of
1a(OH)ase expression [19]. CaR
+/2 and 1a(OH)ase
+/2 mice were
fertile and were mated to produce offspring heterozygous at both
loci, which were then mated to generate CaR
2/21a(OH)ase
2/2
pups. CaR
2/2PTH
2/2 pups were generated in the same way as
above. Lines were maintained by mating CaR
+/21a(OH)ase
+/2
males and females. These mice were of mixed genetic background,
with contributions from C57BL/6J/129/SvJ and 129/SvEv/
BALB/c strains. Mutant mice and control littermates were
maintained in a virus- and parasite-free barrier facility and exposed
to a 12-h/12-h light/dark cycle, and were fed a regular rodent diet.
The use of animals in this study was approved by the Institutional
Animal Care and Use Committee of Nanjing Medical University
(Approval ID 2008-00518).
Genotyping of mice
Tail fragment genomic DNA was isolated by standard phenol–
chloroform extraction and isopropanol precipitation. To deter-
mine the genotype at the CaR, PTH and 1a(OH)ase loci, six PCR
amplification reactions were conducted. To assay the presence of
the wild-type CaR allele, samples were amplified with CaR
forward primer (59-TCT GTT CTC TTT AGG TCC TGA AAC
A-39) and CaR reverse primer (59-TCA TTG ATG AAC AGT
CTT TCT CCC T-39). To detect the presence of the null CaR
allele, Neo forward primer r-Neo-2 (59-TCT TGA TTC CCA
CTT TGT GGT TCT A-39) was used with the CaR reverse
primer. The presence of the wild-type Pth allele was detected using
PTH forward primer (59-GAT GTC TGC AAA CAC CGT GGC
TAA-39) and PTH reverse primer (59-TCC AAA GTT TCA TTA
CAG TAG AAG-39). The null Pth allele was detected using Neo
forward primer (59-TCTTGATTCCCACTTTGTGGTTCTA-
39) and PTH reverse primer [10]. For the wild-type Cyp27b1
[1a(OH)ase] allele, forward primer (59-AGACTGCACTC-
CACTCTGAG-39) and reverse primer (59-GTT TCC TAC
ACG GAT GTC TC-39) were employed. The neomycin gene was
detected with primers neo-F (59-ACA ACA GAC AAT CGG
CTG CTC-39), and neo-R (59-CCA TGG GTC ACG ACG AGA
TC-39) [25]. All PCR reactions were performed with 1 cycle of
95uC for 4 minutes, and 35 cycles of 94uC for 30 seconds, 55uC for
30 seconds, 72uC for 30 seconds.
Biochemical and hormone analyses
Serum calcium and phosphorus were determined by autoana-
lyzer (Beckman Synchron 67; Beckman Instruments). Serum
1,25(OH)2D3 was measured by radioimmunoassay (ImmunoDi-
agnostic Systems, Bolden, UK) and intact PTH was measured by a
two-site immunoradiometric assay (Immutopics, San Clemente,
CA, USA).
Radiography
Femurs were removed and dissected free of soft tissue. Contact
radiographs were taken using a Faxitron model 805 radiographic
inspection system (Faxitron Contact, Faxitron, Germany) (22 kV
voltage and 4 min exposure time). X-Omat TL film (Eastman
Kodak Co., Rochester, NY, USA) was used and processed
routinely.
Micro-computed tomography
Tibias obtained from 2-week-old mice were dissected free of
soft tissue, fixed overnight in 70% ethanol and analyzed by
micro-CT with a SkyScan 1072 scanner and associated analysis
software (SkyScan, Antwerp, Belgium) as described [22].
Briefly, image acquisition was performed at 100 kV and
98 mA with a 0.98 rotation between frames. During scanning,
the samples were enclosed in tightly fitting plastic wrap to
prevent movement and dehydration. Thresholding was applied
to the images to segment the bone from the background. Two-
dimensional images were used to generate three-dimensional
renderings using the 3D Creator software supplied with the
instrument. The resolution of the micro-CT images is 11.26
microns.
Histology
Thyroparathyroid tissue and tibias were removed and fixed
in PLP fixative (2% paraformaldehyde containing 0.075 M
lysine and 0.01 M sodium periodate) overnight at 4uCa n d
processed histologically as described [47]. Tibias were decal-
cified in ethylene- diamine tetraacetic acid (EDTA)-glycerol
solution for 5–7 days at 4uC. Decalcified bones and other
tissues were dehydrated and embedded in paraffin after which
5 mm sections were cut on a rotary microtome. The sections
were stained with hematoxylin and eosin (H&E) or histochem-
ically for tartrate-resistant acid phosphatase (TRAP) activity
and for total collagen or immunohistochemical staining for
osteocalcin (OCN), parathyroid hormone-related protein
(PTHrP) and proliferating cell nuclear antigen (PCNA) as
described subsequently. Alternatively, undecalcified tibiae were
embedded in LR White acrylic resin (London Resin Company
Ltd., London, UK) and 1-mm sections were cut on an
ultramicrotome. These sections were stained for mineral with
the von Kossa staining procedure. Histomorphometric indices
were determined as suggested by the ASBMR Histomorphom-
etry Nomenclature Committee [48].
Histochemical staining for total collagen and TRAP
Total collagen was detected in paraffin sections using a modified
method of Lopez-De Leon and Rojkind [25]. Dewaxed sections
were exposed to 1% sirius red in saturated picric acid for 1 h. After
washing with distilled water, the sections were counterstained with
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histochemistry for TRAP staining was performed as previously
described [8]. Dewaxed sections were preincubated for 20 min in
buffer containing 50 mM sodium acetate and 40 mM sodium
tartrate at pH 5.0. Sections were then incubated for 15 min at
room temperature in the same buffer containing 2.5 mg/ml
naphthol AS-MX phosphate (Sigma-Aldrich, St. Louis, MO) in
dimethylformamide as substrate and 0.5 mg/ml fast garnet GBC
(Sigma-Aldrich) as a color indicator for the reaction product. After
washing with distilled water, the sections were counterstained with
methyl green and mounted in Kaiser’s glycerol.
Immunohistochemical staining
Osteocalcin, parathyroid hormone-related protein (PTHrP) and
proliferating cell nuclear antigen (PCNA) were determined by
immunohistochemistry using the avidin-biotin-peroxidase com-
plex technique with an affinity-purified, goat anti-mouse osteo-
calcin antibody (Biomedical Technologies, Inc., Stoughton MA,
USA), a mouse anti-PCNA monoclonal antibody (Medicorp Inc.,
Montreal, Canada) and a rabbit anti-serum against PTHrP[1–34],
as described previously [8,33,47]. Briefly, the primary antibodies
were applied to dewaxed paraffin sections overnight at room
temperature. As a negative control, pre-immune serum was
substituted for the primary antibody. After washing with high salt
buffer (50 mM Tris–HCl, 2.5% NaCl, 0.05% Tween 20, pH 7.6)
for 10 min at room temperature followed by two 10 min washes
with TBS, the sections were incubated with secondary antibody
(biotinylated goat anti-mouse IgG, Sigma), washed as before and
incubated with the Vectastain Elite ABC kit (Vector Laboratories,
Inc. Ontario, Canada) for 45 min. After washing as before, brown
pigmentation to demarcate regions of immunostaining was
produced by a 10–15 min treatment with the DAB kit (Vector
Laboratories, Inc.). After washing with distilled water, the sections
were counterstained with hematoxylin.
Computer-assisted image analysis
Sections stained histochemically or immunohistochemically
were photographed with a digital camera. Images of micrographs
from single sections were digitally recorded using a rectangular
template, and recordings were processed and analyzed using
Northern Eclipse image analysis software as described [22,47,49].
Parathyroid gland size was quantitated in H & E stained sections
using Northern Eclipse image analysis software and were
presented as parathyroid areas (mm
2).
Quantitative real-time PCR
RNA was isolated from mouse bone tissues, using Trizol reagent
(Invitrogen) according to the manufacturer’s protocol. Reverse
transcription reactions were performed using the SuperScript
First-Strand Synthesis System (Invitrogen) as previously described
[22,33]. To determine the number of cDNA molecules in the
reverse-transcribed samples, real-time PCR was performed using a
LightCycler system (Roche Molecular Biochemicals, Indianapolis,
IN, USA). PCR was performed using 2 ml LightCycler DNA
Master SYBR Green I (Roche), 12.5 ml of reaction mixture, 2 mlo f
each 59 and 39 primer, 2 ml samples and then H2O was added to a
final volume of 25 ml. Samples were denatured at 95uC for 10 sec,
with a temperature transition rate of 20uC per sec. Amplification
and fluorescence determination were carried out in four steps:
denaturation at 95uC for 1 sec, with a temperature transition rate
of 20uC /sec; annealing for 5 sec, with a temperature transition
rate of 8uC /sec; extension at 72uC for 20 sec, with a temperature
transition rate of 4uC /sec; and detection of SYBR Green
fluorescence, which reflects the amount of double-stranded DNA,
at 86uC for 3 sec. The amplification cycle number was 35. To
discriminate specific from nonspecific cDNA products, a melting
curve was obtained at the end of each run. Products were
denatured at 95uC for 3 sec, and the temperature was then
decreased to 58uC for 15 sec and raised slowly from 58 to 95uC
using a temperature transition rate of 0.1uC /sec. To determine
the number of copies of the targeted DNA in the samples, purified
PCR fragments of known concentrations were serially diluted and
served as external standards that were measured in each
experiment. Data were normalized with GAPDH levels in the
samples. The primer sequences used for the real-time PCR were
the same as those used for routine PCR.
Statistical analysis
Data from image analysis are presented as mean 6 SEM.
Statistical comparisons were made using a two-way ANOVA, with
P,0.05 being considered significant.
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